QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
Positive News SentimentPositive News
NASDAQ:KROS

Keros Therapeutics (KROS) News Today

$30.85
0.00 (0.00%)
(As of 10/4/2023 ET)
Compare
Today's Range
$30.23
▼
$31.06
50-Day Range
$30.82
▼
$41.97
52-Week Range
$30.23
▼
$59.96
Volume
102,147 shs
Average Volume
209,212 shs
Market Capitalization
$915.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$94.33
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media
SourceHeadline
finance.yahoo.com logoKeros Therapeutics Presents Preclinical Data from its KER-065 Program at the 28th International Annual Congress of the World Muscle Society
finance.yahoo.com - October 4 at 9:56 AM
marketbeat.com logoSG Americas Securities LLC Reduces Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - September 30 at 4:12 AM
marketbeat.com logoWCM Investment Management LLC Purchases 11,187 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - September 24 at 6:40 AM
marketbeat.com logoCandriam S.C.A. Purchases 119,143 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - September 8 at 8:51 AM
marketbeat.com logoAmerican Century Companies Inc. Invests $4.82 Million in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - September 7 at 4:46 AM
markets.businessinsider.com logoWedbush Sticks to Their Buy Rating for Keros Therapeutics (KROS)
markets.businessinsider.com - August 31 at 5:19 PM
marketbeat.com logoCitigroup Inc. Cuts Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - August 29 at 5:58 AM
marketbeat.com logoKeros Therapeutics, Inc. (NASDAQ:KROS) Stock Holdings Decreased by Barclays PLC
marketbeat.com - August 21 at 4:34 AM
nasdaq.com logoBenjamin Graham Detailed Fundamental Analysis - KROS
nasdaq.com - August 20 at 9:12 PM
marketbeat.com logoKeros Therapeutics, Inc. (NASDAQ:KROS) Shares Purchased by CHI Advisors LLC
marketbeat.com - August 11 at 10:22 PM
marketbeat.com logoKeros Therapeutics, Inc. (NASDAQ:KROS) to Post Q3 2023 Earnings of ($1.46) Per Share, HC Wainwright Forecasts
marketbeat.com - August 10 at 7:11 AM
markets.businessinsider.com logoAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Cigna (CI), Keros Therapeutics (KROS) and Qiagen (QGEN)
markets.businessinsider.com - August 9 at 8:15 AM
markets.businessinsider.com logoTruist Financial Remains a Buy on Keros Therapeutics (KROS)
markets.businessinsider.com - August 9 at 3:15 AM
msn.com logoWedbush Reiterates Keros Therapeutics (KROS) Outperform Recommendation
msn.com - August 8 at 5:14 PM
finanznachrichten.de logoKeros Therapeutics, Inc.: Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
finanznachrichten.de - August 8 at 2:09 AM
markets.businessinsider.com logoWedbush Sticks to Its Buy Rating for Keros Therapeutics (KROS)
markets.businessinsider.com - August 8 at 2:09 AM
finance.yahoo.com logoKeros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
finance.yahoo.com - August 7 at 8:30 AM
seekingalpha.com logoKeros Therapeutics: Hematological Therapies Continue To Advance
seekingalpha.com - August 2 at 1:19 PM
markets.businessinsider.com logoWedbush Initiates a Buy Rating on Keros Therapeutics (KROS)
markets.businessinsider.com - July 31 at 11:54 AM
finance.yahoo.com logoCorrected: Keros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
finance.yahoo.com - July 27 at 8:39 PM
markets.businessinsider.com logoWhere Keros Therapeutics Stands With Analysts
markets.businessinsider.com - July 26 at 9:53 PM
marketbeat.com logoKeros Therapeutics (NASDAQ:KROS) Now Covered by Analysts at Bank of America
marketbeat.com - July 26 at 5:53 PM
finance.yahoo.com logoKeros Therapeutics to Host Conference Call and Webcast to Provide an Overview of TROPOS, the KER-012 Phase 2 Clinical Trial in Patients with Pulmonary Arterial Hypertension
finance.yahoo.com - July 24 at 9:28 AM
fool.com logoKeros Therapeutics (NASDAQ: KROS)
fool.com - July 23 at 8:10 AM
marketbeat.com logoShort Interest in Keros Therapeutics, Inc. (NASDAQ:KROS) Expands By 19.7%
marketbeat.com - June 16 at 6:55 PM
finance.yahoo.com logoKeros Therapeutics Announces Update to Participation at the Goldman Sachs 44th Annual Global Healthcare Conference
finance.yahoo.com - June 12 at 4:54 PM
markets.businessinsider.com logoH.C. Wainwright Remains a Buy on Keros Therapeutics (KROS)
markets.businessinsider.com - June 9 at 12:36 PM
marketbeat.com logoKeros Therapeutics, Inc. (NASDAQ:KROS) Position Decreased by CIBC Asset Management Inc
marketbeat.com - June 9 at 8:05 AM
finance.yahoo.com logoKeros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 28th Annual Congress of the European Hematology Association
finance.yahoo.com - June 9 at 7:35 AM
marketbeat.com logoGSA Capital Partners LLP Makes New $392,000 Investment in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - June 8 at 6:16 AM
finance.yahoo.com logoKeros Therapeutics to Present at Goldman Sach’s 44th Annual Global Healthcare Conference
finance.yahoo.com - June 7 at 10:15 AM
marketbeat.com logoPrincipal Financial Group Inc. Takes Position in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - June 7 at 5:27 AM
marketbeat.com logoUBS Group AG Has $2.36 Million Stock Position in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - June 4 at 4:30 AM
marketbeat.com logo21,222 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Purchased by HRT Financial LP
marketbeat.com - June 1 at 6:43 AM
markets.businessinsider.com logoKeros Therapeutics (KROS) Receives a Rating Update from a Top Analyst
markets.businessinsider.com - May 29 at 6:18 PM
marketbeat.com logoOpaleye Management Inc. Has $11.43 Million Holdings in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - May 26 at 2:49 PM
marketbeat.com logo4,360 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Purchased by Arizona State Retirement System
marketbeat.com - May 25 at 4:29 AM
markets.businessinsider.com logoAnalysts Have Conflicting Sentiments on These Healthcare Companies: Rain Therapeutics (RAIN) and Keros Therapeutics (KROS)
markets.businessinsider.com - May 23 at 12:45 AM
finance.yahoo.com logoKeros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
finance.yahoo.com - May 22 at 9:44 AM
marketbeat.com logoRussell Investments Group Ltd. Purchases 16,348 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - May 22 at 5:18 AM
marketbeat.com logoCitigroup Inc. Sells 64,020 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - May 16 at 6:17 AM
marketbeat.com logoTD Asset Management Inc Invests $480,000 in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - May 12 at 4:42 AM
finance.yahoo.com logoKeros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association
finance.yahoo.com - May 11 at 5:42 PM
msn.com logoHC Wainwright & Co. Reiterates Keros Therapeutics (KROS) Buy Recommendation
msn.com - May 9 at 8:51 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Karuna Therapeutics (KRTX) and Keros Therapeutics (KROS)
markets.businessinsider.com - May 8 at 8:20 AM
seekingalpha.com logoKeros Therapeutics GAAP EPS of -$1.26
seekingalpha.com - May 7 at 3:01 PM
nasdaq.com logoPiper Sandler Maintains Keros Therapeutics (KROS) Overweight Recommendation
nasdaq.com - May 6 at 7:53 AM
finanznachrichten.de logoKeros Therapeutics, Inc.: Keros Therapeutics Reports Recent Business Highlights and First Quarter 2023 Financial Results
finanznachrichten.de - May 5 at 4:05 PM
marketbeat.com logoKeros Therapeutics (NASDAQ:KROS) Releases Earnings Results
marketbeat.com - May 5 at 12:53 PM
marketbeat.com logoProShare Advisors LLC Takes Position in Keros Therapeutics, Inc. (NASDAQ:KROS)
marketbeat.com - May 5 at 4:42 AM
Get Keros Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KROS and its competitors with MarketBeat's FREE daily newsletter.



KROS Media Mentions By Week

KROS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KROS
News Sentiment
▼
1.81

0.41
▲
Average
Medical
News Sentiment

KROS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KROS Articles
This Week
▼
2

1
▲
KROS Articles
Average Week

Get Keros Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for KROS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:KROS) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -